4/A

FORM 4/A SUBMISSION

Company: PUMA BIOTECHNOLOGY, INC.
Filed: February 23, 2021
Period of Report: February 17, 2021
Accession Number: 0001209191-21-013211

View Document ↗ View on SEC.gov ↗